Posted On: 04/16/2014 12:36:02 PM
Post# of 36729
It's good fins clarified IP issue with IP reverting to Medical Greens after Dec 31, 2013. In the matter of revenues, market is evidently cautious as witness price performance.
The $25m in bad debt on top of $12m of bad debt in Q3 report equals $37m in bad debt for period March 11, 2013 to Dec 31, 2013 pertaining to accounts receivable. In SKTO EOY 2013, the market sees $27m in new "net receivables" and only $153k in cash and the juxtaposition understandably leads to caution if not skepticism lest those receivables later be listed as bad debt. By definition a receivable is a claim on money due, "an asset designation applicable to all debts, unsettled transactions or other monetary obligations owed to a company by its debtors or customers."
Others risk factors potentially weighing on price appreciation were noted here: http://investorshangout.com/post/view?id=1408773
I'm delighted IP has returned.
The $25m in bad debt on top of $12m of bad debt in Q3 report equals $37m in bad debt for period March 11, 2013 to Dec 31, 2013 pertaining to accounts receivable. In SKTO EOY 2013, the market sees $27m in new "net receivables" and only $153k in cash and the juxtaposition understandably leads to caution if not skepticism lest those receivables later be listed as bad debt. By definition a receivable is a claim on money due, "an asset designation applicable to all debts, unsettled transactions or other monetary obligations owed to a company by its debtors or customers."
Others risk factors potentially weighing on price appreciation were noted here: http://investorshangout.com/post/view?id=1408773
I'm delighted IP has returned.
(0)
(0)
